A Clinical Trial to Evaluate AZD7648 Alone and in Combination With Other Anti-cancer Agents in Patients With Advanced Cancers
Condition: Advanced Malignancies Interventions: Drug: AZD7648; Drug: Pegylated liposomal doxorubicin (PLD); Drug: Olaparib Sponsors: AstraZeneca; Parexel Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials